Mickle Travis C 4
4 · KEMPHARM, INC · Filed Nov 23, 2021
Insider Transaction Report
Form 4
KEMPHARM, INCKMPH
Mickle Travis C
DirectorPresident & CEO10% Owner
Transactions
- Purchase
Common Stock
2021-11-18$8.23/sh+2,250$18,516→ 36,521 total
Holdings
- 15,242(indirect: By Trust)
Common Stock
- 1,034(indirect: By LLC)
Common Stock
- 9,824(indirect: By Trust)
Common Stock
- 96,153(indirect: By LLC)
Common Stock
Footnotes (2)
- [F1]The Reporting Person is the sole manager member of Mickle Investments, LLC.
- [F2]The Reporting Person is the sole manager member of Mickle Holdings, LLC.